Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Core Clinical Centers (U10)
ArchivedNational Institutes of Health
Description
Purpose. This Funding Opportunity Announcement (FOA) issued by the National Heart, Lung, and Blood Institute (NHLBI) and the National Cancer Institute (NCI), National Institutes of Health, invites applications from investigators willing to participate under a cooperative agreement as Core Clinical Centers in the Blood and Marrow Transplant Clinical Trials Network (BMT CTN), a collaborative multicenter clinical program that promotes the efficient comparison of novel treatment approaches and management strategies for potential benefit of children and adults undergoing hematopoietic stem cell transplantation. This is an open competition for the renewal of an existing network. Mechanism of Support. This FOA will utilize the U10 NIH Cooperative Clinical Research Agreement grant mechanism. Funds Available and Anticipated Number of Awards. NHLBI and NCI intend to commit up to $63.5 million over six years to fund up to 19 Core Clinical Centers with expertise in hematopoietic stem cell transplantation (HSCT) and a Data Coordinating Center (DCC) to support the program. Investigators interested in applying as DCC for the BMT CTN program should refer to the companion Request for Applications (RFA-HL-11-028).
Who can apply
- Public and State controlled institutions of higher education
- Nonprofits with 501(c)(3) status (other than higher education)
- Nonprofits without 501(c)(3) status (other than higher education)
- Private institutions of higher education
- For-profit organizations other than small businesses
- Others
Contact
NIH OER Webmaster<br/>FBOWebmaster@OD.NIH.GOV<br/>
FBOWebmaster@OD.NIH.GOV
- PostedAug 11, 2010
- ClosesOct 13, 2010
- Award ceiling$115,000
- CFDA93.395, 93.839
Pro insight
Edit and export this grant’s proposal template, plus deadline reminders, similar-grant suggestions, and funder history — all available with Pro.
Unlock with Pro